| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_048120d2d7536e9854588bb1fb88fbd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0607c02c591c0881c2f44175cb4a1a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_351266bb714df09224a7007992c9998a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c59eccbb6de22c1d3c8b68f789e58e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_338e90b0d9255aef9684c28b312a557d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate |
2007-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de5153fbeb5411ec0501c1ef9dff7314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfa0f22d51d5ea30c577a642729f1a9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01829209c88ef578b17a015729219781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8bb09427aa89c44f1812075f9756fec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d24a78667248f6435b062f1adb5302 |
| publicationDate |
2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008146558-A1 |
| titleOfInvention |
4,5,6,7-Tetrahydro-Thieno [3,2-C] Pyridine Derivatives |
| abstract |
The present invention relates to compounds of formula I n n n n n n n n n n wherein R 1 and R 2 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors. |
| priorityDate |
2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |